| Serial Number | 88282125 |
| Word Mark | KBI BIOPHARMA |
| Filing Date | Wednesday, January 30, 2019 |
| Status | 702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED |
| Status Date | Wednesday, January 15, 2025 |
| Registration Number | 5839075 |
| Registration Date | Tuesday, August 20, 2019 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, June 4, 2019 |
| Goods and Services | contract manufacturing in the field of biopharmaceuticals |
| Description of Mark | The mark consists of three disk-shaped objects connected by a diagonal line. Two of the discs are orange and one is dark blue. The connecting line is white. The term "KBI" is in dark blue above the term "BIOPHARMA" is in orange and is displayed in uppercase letters to the right of the disk-shaped objects. The color white is not claimed as a feature of the mark and represents transparent areas. |
| Indication of Colors claimed | The color(s) orange and dark blue is/are claimed as a feature of the mark. |
| NOT AVAILABLE | "BIOPHARMA" |
| Goods and Services | contract biopharmaceutical drug development services |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, February 22, 2019 |
| Primary Code | 040 |
| First Use Anywhere Date | Tuesday, May 1, 2012 |
| First Use In Commerce Date | Tuesday, May 1, 2012 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, February 22, 2019 |
| Primary Code | 042 |
| First Use Anywhere Date | Tuesday, May 1, 2012 |
| First Use In Commerce Date | Tuesday, May 1, 2012 |
| Party Name | KBI Biopharma, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Durham, NC 27704 |
| Party Name | KBI Biopharma, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Durham, NC 27704 |
| Party Name | KBI Biopharma, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Durham, NC 27704 |
| Event Date | Event Description |
| Saturday, February 2, 2019 | NEW APPLICATION ENTERED |
| Friday, February 22, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, March 21, 2019 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Thursday, April 11, 2019 | ASSIGNED TO EXAMINER |
| Tuesday, April 16, 2019 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, April 16, 2019 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, April 16, 2019 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, April 16, 2019 | EXAMINER'S AMENDMENT ENTERED |
| Monday, April 29, 2019 | ASSIGNED TO LIE |
| Tuesday, June 4, 2019 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 4, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, April 16, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, April 30, 2019 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Wednesday, May 15, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, August 20, 2019 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, August 20, 2024 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Wednesday, August 21, 2024 | TEAS SECTION 8 & 15 RECEIVED |
| Wednesday, January 15, 2025 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Wednesday, January 15, 2025 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| Wednesday, January 15, 2025 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |